According to Chugai Pharmaceutical's latest financial reports the company's current earnings (TTM) are $3.33 B. In 2022 the company made an earning of $4.06 B an increase over its 2021 earnings that were of $3.73 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $3.33 B | -17.92% |
2022 | $4.06 B | 8.82% |
2021 | $3.73 B | 32.69% |
2020 | $2.81 B | 47.31% |
2019 | $1.90 B | 72.77% |
2018 | $1.10 B | 27.77% |
2017 | $0.86 B | 24.88% |
2016 | $0.69 B | -4.23% |
2015 | $0.72 B | 2% |
2014 | $0.70 B | -8.93% |
2013 | $0.77 B | -14.98% |
2012 | $0.91 B | 26.86% |
2011 | $0.72 B | -5.93% |
2010 | $0.76 B | -19.02% |
2009 | $0.94 B |